Cancer Incidence and Mortality for All Sites of Cancer, Richmond County (Staten Island), 2010-2014

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males Females Males Females
Average Annual Cases Rate per 100,000 Males 95% CI (+/-) Average Annual Cases Rate per 100,000 Females 95% CI (+/-) Average Annual Deaths Rate per 100,000 Males 95% CI (+/-) Average Annual Deaths Rate per 100,000 Females 95% CI (+/-)
All Invasive Malignant Tumors 1355.2 569.0 14.0 1412.2 486.7 11.6 415.4 188.5 8.4 398.8 132.3 5.9
Oral cavity and pharynx
All Oral cavity and pharynx 36.2 14.2 2.1 18.8 6.4 1.3 5.4 2.2 0.9 3.6 1.2 0.6
Lip 0.4 0.1 0.2 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0
Tongue 11.6 4.4 1.2 5.4 1.9 0.7 1.6 0.6 0.4 0.6 0.2 0.2
Salivary gland 3.6 1.6 0.8 2.8 0.9 0.5 0.4 0.2 0.3 0.4 0.1 0.2
Floor of mouth 1.6 0.6 0.4 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0
Gum & other mouth 4.4 2.0 0.8 4.2 1.4 0.6 0.6 0.2 0.3 0.4 0.1 0.2
Nasopharynx 3.2 1.2 0.6 1.8 0.6 0.4 0.8 0.3 0.3 0.8 0.3 0.3
Tonsil 7.0 2.5 0.9 1.8 0.6 0.4 0.4 0.1 0.2 0.0 0.0 0.0
Oropharynx 1.4 0.6 0.4 0.6 0.2 0.2 0.2 0.1 0.2 0.4 0.1 0.2
Hypopharynx 2.2 0.9 0.5 0.4 0.2 0.2 0.2 0.1 0.2 0.2 0.1 0.1
Other buccal cavity and pharynx 0.8 0.2 0.2 1.0 0.3 0.3 1.2 0.5 0.4 0.8 0.3 0.3
Digestive system
All Digestive system 261.4 110.2 6.2 213.6 71.4 4.4 129.6 56.7 4.5 100.0 32.6 2.9
Esophagus 13.6 5.7 1.4 3.6 1.2 0.6 12.8 5.3 1.3 3.2 1.1 0.6
Stomach 25.4 10.9 2.0 18.0 6.2 1.3 11.6 4.9 1.3 7.6 2.3 0.7
Small intestine 7.0 3.0 1.0 5.6 1.8 0.7 0.2 0.1 0.1 0.4 0.1 0.2
Colorectal 121.6 52.4 4.3 117.2 39.0 3.2 45.0 21.1 2.8 41.0 13.4 1.9
Colon excluding rectum 83.4 36.5 3.6 88.2 29.2 2.8 37.8 18.0 2.6 35.2 11.5 1.7
Cecum 11.6 5.3 1.4 22.2 7.4 1.4            
Appendix 1.6 0.7 0.5 4.0 1.5 0.7            
Ascending colon 15.6 6.7 1.5 18.4 6.2 1.3            
Hepatic flexure 3.6 1.8 0.8 3.2 1.1 0.5            
Transverse colon 9.0 4.1 1.2 7.4 2.4 0.8            
Splenic flexure 2.4 1.0 0.6 0.8 0.3 0.3            
Descending colon 5.8 2.5 0.9 4.8 1.6 0.6            
Sigmoid colon 27.8 11.8 2.0 21.8 7.1 1.4            
Large intestine, NOS 6.0 2.7 1.0 5.6 1.8 0.7            
Rectum & rectosigmoid 38.2 16.0 2.3 29.0 9.8 1.6 7.2 3.2 1.1 5.8 1.9 0.7
Rectosigmoid junction 11.4 5.0 1.3 11.2 3.9 1.0            
Rectum 26.8 10.9 1.9 17.8 5.9 1.3            
Anus, anal canal & anorectum 4.0 1.7 0.8 4.0 1.2 0.6 0.6 0.3 0.3 1.0 0.3 0.3
Liver and intrahepatic bile duct 44.0 17.1 2.3 15.0 4.9 1.1 28.4 11.6 2.0 11.8 3.9 1.0
Liver 39.2 15.0 2.2 11.2 3.7 1.0 22.6 9.2 1.8 8.2 2.7 0.8
Intrahepatic bile duct 4.8 2.0 0.8 3.8 1.2 0.6 5.8 2.4 0.9 3.6 1.2 0.6
Gallbladder 1.2 0.5 0.4 4.6 1.7 0.7 1.8 0.8 0.6 2.8 1.0 0.5
Other biliary 4.6 1.8 0.8 4.0 1.4 0.6 0.4 0.2 0.3 1.0 0.3 0.3
Pancreas 36.4 15.4 2.3 36.4 12.1 1.8 28.2 12.1 2.1 29.8 9.8 1.6
Retroperitoneum 1.2 0.6 0.5 1.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0
Peritoneum, omentum & mesentery 0.4 0.2 0.3 3.4 1.1 0.5 0.4 0.2 0.3 0.8 0.2 0.2
Other digestive organs 2.0 0.9 0.6 0.8 0.3 0.3 0.2 0.1 0.1 0.6 0.2 0.3
Respiratory system
All Respiratory system 200.4 86.0 5.5 173.8 58.9 4.0 123.0 55.3 4.5 103.8 35.0 3.1
Nasal cavity, middle ear & sinuses 3.8 1.8 0.8 1.2 0.5 0.4 0.2 0.1 0.1 0.4 0.2 0.2
Larynx 17.4 7.0 1.5 6.2 2.1 0.8 4.8 2.2 0.9 1.6 0.5 0.4
Lung and bronchus 178.8 77.1 5.2 165.6 56.0 3.9 117.8 52.9 4.4 101.8 34.3 3.0
Pleura 0.0 0.0 0.0 0.4 0.2 0.3 0.2 0.1 0.2 0.0 0.0 0.0
Trachea, mediastinum, other respiratory 0.4 0.2 0.2 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0
Soft tissue, bone, and skin
Bones & joints 2.4 1.1 0.6 1.6 0.6 0.5 0.8 0.4 0.4 0.2 0.1 0.1
Soft tissue (including heart) 9.0 3.9 1.2 8.6 3.1 1.0 3.6 1.6 0.8 2.6 0.9 0.5
Skin~ 55.8 24.1 2.9 43.8 15.3 2.1 8.2 3.7 1.2 4.2 1.5 0.6
Melanoma of the skin 51.0 21.9 2.8 39.8 13.9 2.0 6.2 2.7 1.0 3.4 1.2 0.6
Breast
Breast 2.4 1.0 0.6 386.0 131.8 6.0 0.6 0.3 0.3 61.0 20.0 2.3
Female genital system
All Female genital system       173.4 58.7 4.0       48.2 15.7 2.0
Cervix uteri       18.4 6.7 1.4       6.8 2.3 0.8
Corpus uterus and NOS       104.4 34.7 3.0       15.8 5.3 1.2
Ovary       36.8 12.6 1.9       23.2 7.5 1.4
Vagina       2.4 0.8 0.5       1.2 0.4 0.3
Vulva       8.2 2.7 0.9       0.8 0.2 0.2
Other female genital organs       3.2 1.2 0.6       0.4 0.1 0.2
Male genital system
All Male genital system 340.2 135.1 6.6       35.2 18.6 2.8      
Prostate 324.8 128.2 6.4       34.2 18.1 2.8      
Testis 12.6 5.6 1.4       0.6 0.3 0.3      
Penis 2.0 0.9 0.6       0.4 0.2 0.3      
Other male genital organs 0.8 0.3 0.3       0.0 0.0 0.0      
Urinary system
All Urinary system 169.4 72.6 5.1 66.2 22.3 2.5 29.4 13.6 2.3 14.8 4.9 1.1
Urinary bladder (including in situ) 99.2 44.1 4.0 29.8 9.7 1.6 18.6 9.0 1.9 7.2 2.2 0.7
Kidney and renal pelvis 64.0 25.4 2.9 34.4 12.0 1.8 10.2 4.4 1.2 7.2 2.5 0.8
Ureter 2.6 1.4 0.7 1.2 0.4 0.3 0.4 0.2 0.3 0.2 0.1 0.2
Other urinary organs 3.6 1.7 0.8 0.8 0.2 0.2 0.2 0.1 0.1 0.2 0.1 0.1
Eye & orbit
Eye & orbit 2.4 1.1 0.6 2.6 0.9 0.5 0.2 0.1 0.1 0.0 0.0 0.0
Brain and central nervous system
All Brain / other nervous system (all behaviors) 35.6 15.2 2.3 60.6 21.8 2.5 13.8 5.9 1.4 11.0 3.8 1.0
Malignant brain / other nervous system 18.4 8.1 1.7 16.2 6.1 1.4 12.0 5.2 1.4 9.6 3.3 1.0
Malignant brain 17.2 7.6 1.6 14.6 5.4 1.3            
Malignant other nervous system 1.2 0.5 0.4 1.6 0.7 0.5            
Benign brain / other nervous system* 17.2 7.1 1.5 44.4 15.7 2.1 1.8 0.7 0.5 1.4 0.5 0.4
Benign brain 2.6 1.2 0.7 3.0 1.3 0.7            
Benign other nervous system 14.6 5.9 1.4 41.4 14.4 2.0            
Endocrine system
All Endocrine system 46.0 18.7 2.5 128.6 48.9 3.9 1.4 0.5 0.4 1.8 0.7 0.4
Thyroid 43.4 17.7 2.4 125.4 47.6 3.8 1.0 0.4 0.3 0.6 0.2 0.2
Other endocrine (including thymus) 2.6 1.1 0.6 3.2 1.3 0.6 0.4 0.2 0.2 1.2 0.5 0.4
Lymphomas
All Lymphomas 72.4 31.5 3.3 68.4 24.2 2.6 16.6 7.8 1.7 11.6 4.0 1.0
Hodgkin lymphoma 8.8 3.8 1.1 9.6 4.0 1.1 1.0 0.4 0.4 0.6 0.2 0.2
Non-Hodgkin lymphomas 63.6 27.8 3.1 58.8 20.3 2.4 15.6 7.3 1.7 11.0 3.8 1.0
Myeloma
All Myeloma 27.8 11.9 2.1 19.6 6.5 1.3 5.8 2.6 1.0 5.8 2.0 0.7
Leukemias
All Leukemias 52.0 22.8 2.9 42.2 15.1 2.1 18.2 8.2 1.7 13.0 4.5 1.1
Lymphocytic leukemias 29.6 13.0 2.2 22.0 7.7 1.5 4.2 1.9 0.8 3.8 1.3 0.6
Acute lymphocytic leukemia 4.6 2.1 0.9 4.2 1.8 0.8 1.0 0.4 0.4 0.4 0.1 0.2
Chronic lymphocytic leukemia 22.0 9.5 1.8 17.2 5.7 1.2 3.0 1.4 0.7 3.4 1.1 0.5
Other lymphocytic leukemias 3.0 1.3 0.7 0.6 0.2 0.2 0.2 0.1 0.1 0.0 0.0 0.0
Myeloid and monocytic leukemias 20.2 8.9 1.8 17.4 6.4 1.4 10.2 4.6 1.3 6.0 2.1 0.8
Acute myeloid leukemia 11.6 5.2 1.4 11.4 4.2 1.1 8.4 3.9 1.2 5.0 1.8 0.7
Acute monocytic leukemia 0.6 0.3 0.4 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0
Chronic myeloid leukemia 6.4 2.6 0.9 4.6 1.7 0.7 0.8 0.3 0.3 0.2 0.1 0.1
Other myeloid/monocytic leukemias 1.6 0.8 0.6 1.0 0.4 0.4 1.0 0.3 0.3 0.8 0.3 0.3
Other leukemias 2.2 0.9 0.5 2.8 0.9 0.5 3.8 1.8 0.8 3.2 1.1 0.6
Other acute leukemias 0.6 0.3 0.3 1.2 0.4 0.3 1.0 0.4 0.4 2.0 0.7 0.4
Aleukemic, subacute, leukemia NOS 1.6 0.6 0.4 1.6 0.5 0.4 2.8 1.3 0.7 1.2 0.4 0.4
Mesothelioma
Mesothelioma 3.6 1.7 0.8 2.0 0.7 0.5            
Kaposi sarcoma
Kaposi sarcoma 2.8 1.4 0.7 0.6 0.2 0.3            
Myelodysplastic syndromes
Myelodysplastic syndromes 14.6 6.7 1.6 8.8 2.9 0.9            
Chronic myeloproliferative disorders^
Chronic myeloproliferative disorders^ 12.4 5.1 1.3 14.0 4.9 1.2            
Ill defined and unspecified sites
Ill defined and unspecified sites 25.6 11.8 2.1 23.4 7.9 1.5 25.4 11.8 2.1 18.6 6.0 1.2

Key

Symbol Meaning
~ Incidence of skin cancer excludes basal and squamous cell cancers.
* Brain and other nervous system tumors with benign or uncertain behaviors are not included in the total for all invasive malignant tumors.
^ Tumors with a histology of 9963 or 9964 are included under Aleukemic, Subacute, Leukemia NOS, instead of Chronic Myeloproliferative Disorder.

Notes

  • Incidence data are provisional, November 2016.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.